.
.
.
.
List of Tables |
1-1 |
|
Target Analytes Recommended for Fish Sampling Programs |
1-2 |
|
Comparison of FDA Action Levels and Tolerances with
EPA Screening Values |
1-3 |
|
Fish Consumption Rates for Various Fisher Populations |
2-1 |
|
Uncertainty Factors and Modifying Factors for Estimating
Exposure Limits for Chronic Effects |
2-2 |
|
Mean Body Weights of Children and Adults |
2-3 |
|
Categories of Information Necessary for a Population
Exposure Assessment |
2-4 |
|
Exposure Data Template |
2-5 |
|
Risk Estimates |
2-6 |
|
Risk Characterization |
2-7 |
|
Risk Summaries for a Waterbody |
2-8 |
|
Risk Summaries for a Geographic Area |
3-1 |
|
Risk Values Used in Risk-Based Consumption Limit Tables |
3-2 |
|
Input Parameters for Use in Risk Equations |
3-3 |
|
Monthly Fish Consumption Limits for Carcinogenic and
Noncarcinogenic Health Endpoints & Chlordane |
3-4 |
|
Monthly Consumption Limits for Carcinogenic and Noncarcinogenic
Health Endpoints- Chlordane |
3-5 |
|
Average Body Weights and Associated Multipliers |
4-1 |
|
Monthly Fish Consumption Limits for Carcinogenic and
Noncarcinogenic Health Endpoints - Arsenic |
4-2 |
|
Monthly Fish Consumption Limits for Noncarcinogenic
Health Endpoint - Cadmium |
4-3 |
|
Monthly Fish Consumption Limits for Noncarcinogenic
Health Endpoint - Methlymercury |
4-4 |
|
Monthly Fish Consumption Limits for Noncarcinogenic
Health Endpoint - Selenium |
4-5 |
|
Monthly Fish Consumption Limits for Noncarcinogenic
Health Endpoint - Tributyltin |
4-6 |
|
Monthly Fish Consumption Limits for Carcinogenic and
Noncarcinogenic Health Endpoints - Chlordane |
4-7 |
|
Monthly Fish Consumption Limits for Carcinogenic and
Noncarcinogenic Health Endpoints - DDT |
4-8 |
|
Monthly Fish Consumption Limits for Noncarcinogenic
Health Endpoint - Dicofol |
4-9 |
|
Monthly Fish Consumption Limits for Carcinogenic and
Noncarcinogenic Health Endpoints -Dieldrin |
4-10 |
|
Monthly Fish Consumption Limits for Noncarcinogenic
Health Endpoint - Endosulfan |
4-11 |
|
Monthly Fish Consumption Limits for Noncarcinogenic
Health Endpoint - Endrin |
4-12 |
|
Monthly Fish Consumption Limits for Carcinogenic and
Noncarcinogenic Health Endpoints - Heptachlor Epoxide |
4-13 |
|
Monthly Fish Consumption Limits for Carcinogenic and
Noncarcinogenic Health Endpoints - Hexachlorobenzene |
4-14 |
|
Monthly Fish Consumption Limits for Carcinogenic and
Noncarcinogenic Health Endpoints - Lindane |
4-15 |
|
Monthly Fish Consumption Limits for Carcinogenic and
Noncarcinogenic Health Endpoints - Mirex |
4-16 |
|
Monthly Fish Consumption Limits for Carcinogenic and
Noncarcinogenic Health Endpoints - Toxaphene |
4-17 |
|
Monthly Fish Consumption Limits for Noncarcinogenic
Health Endpoint - Chlorpyrifos |
4-18 |
|
Monthly Fish Consumption Limits for Noncarcinogenic
Health Endpoint - Diazinon |
4-19 |
|
Monthly Fish Consumption Limits for Noncarcinogenic
Health Endpoint - Disulfoton |
4-20 |
|
Monthly Fish Consumption Limits for Noncarcinogenic
Health Endpoint - Ethion |
4-21 |
|
Monthly Fish Consumption Limits for Noncarcinogenic
Health Endpoint - Terbufos |
4-22 |
|
Monthly Fish Consumption Limits for Noncarcinogenic
Health Endpoint - Oxyfluorfen |
4-23 |
|
Monthly Fish Consumption Limits for Carcinogenic Health
Endpoint - PAHs |
4-24 |
|
Monthly Fish Consumption Limits for Carcinogenic and
Noncarcinogenic Health Endpoints - PCBs |
4-25 |
|
Monthly Fish Consumption Limits for Carcinogenic Health
Endpoint - Dioxins/Furans |
5-1 |
|
Health and Toxicological Data Reviewed for Target Analytes |
5-2 |
|
Toxicity Equivalent Factors for Various PAHs |
5-3 |
|
Relative Potency Estimates for Various PAHs |
5-4 |
|
Reported Concentrations (ppm) of Dioxin-Like Congeners
in Commercial Aroclor Mixtures |
5-5 |
|
PCB and Dioxin Concentrations (ppb) in Channel Catfish |
6-1 |
|
Comparison of Raster- Versus Vector-Based GIS Programs |
|
|
|
.